Leapfrog Micro-Infusion Device
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $45,418 | 26 | 13 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $43,645 | 14 | 96.1% |
| Consulting Fee | $1,000 | 1 | 2.2% |
| Food and Beverage | $773.06 | 11 | 1.7% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Perivenous Dexamethasone Therapy: Examing Reduction of Inflammation after Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT | Mercator MedSystems, Inc. | $43,645 | 5 |
Top Doctors Receiving Payments for Leapfrog Micro-Infusion Device
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Diagnostic Radiology | Pittsburgh, PA | $16,500 | 3 |
| , M.D | Vascular Surgery | Darien, CT | $11,085 | 3 |
| , M.D | Cardiovascular Disease | Mckinney, TX | $6,900 | 1 |
| Unknown | — | Bartlesville, OK | $4,579 | 5 |
| , M.D | Internal Medicine | Columbus, OH | $3,631 | 2 |
| , M.D | Vascular Surgery | Washington, DC | $2,000 | 2 |
| , MD | Surgery | Norfolk, VA | $220.81 | 2 |
| , M.D | Vascular & Interventional Radiology | Orange, CA | $138.32 | 1 |
| , M.D | Pulmonary Disease | Lebanon, NH | $77.34 | 1 |
| , MD | Surgery | Charlotte, NC | $73.89 | 2 |
| , MD | Cardiovascular Disease | Houma, LA | $53.73 | 1 |
| , M.D | Vascular Surgery | Houston, TX | $53.73 | 1 |
| , M.D | Specialist | Columbus, OH | $52.35 | 1 |
| , MD | Undersea and Hyperbaric Medicine | Palo Alto, CA | $52.35 | 1 |
Manufacturing Companies
- Mercator MedSystems, Inc. $45,418
Product Information
- Type Device
- Total Payments $45,418
- Total Doctors 13
- Transactions 26
About Leapfrog Micro-Infusion Device
Leapfrog Micro-Infusion Device is a device associated with $45,418 in payments to 13 healthcare providers, recorded across 26 transactions in the CMS Open Payments database. The primary manufacturer is Mercator MedSystems, Inc..
Payment data is available from 2024 to 2024. In 2024, $45,418 was paid across 26 transactions to 13 doctors.
The most common payment nature for Leapfrog Micro-Infusion Device is "Unspecified" ($43,645, 96.1% of total).
Leapfrog Micro-Infusion Device is associated with 1 research study, including "Perivenous Dexamethasone Therapy: Examing Reduction of Inflammation after Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT" ($43,645).